# Viracta Subsidiary, Inc.: Form D filings

Viracta Subsidiary, Inc., a biotechnology company in Cardiff, CA, filed 11 Form D notices with the SEC between 2010 and 2021. The latest, on March 10, 2021, reports $65 million sold of a $65 million offering to 26 investors.

Find out what Viracta Subsidiary, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Viracta%20Subsidiary%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Viracta%20Subsidiary%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fviracta-subsidiary-inc-1416377)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Viracta%20Subsidiary%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Viracta%20Subsidiary%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fviracta-subsidiary-inc-1416377)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2533 S. Coast Highway 101, Suite 210, Cardiff, CA, 92007
- Phone: (858) 771-4190
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1416377

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 10, 2021 | New notice | $64,999,994 | $64,999,994 | $0 | 26 | Feb 24, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000171595421000002/0001715954-21-000002-index.htm) |
| Dec 10, 2020 | New notice | $40,000,000 | $39,999,997 | $3 | 14 | Nov 25, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637720000001/0001416377-20-000001-index.htm) |
| Nov 5, 2019 | New notice | $24,999,999 | $16,774,987 | $8,225,012 | 21 | Oct 24, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000165736919000002/0001657369-19-000002-index.htm) |
| Feb 12, 2019 | New notice | $5,714,363 | $5,714,363 | $0 | 25 | Jan 31, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637719000003/0001416377-19-000003-index.htm) |
| Feb 12, 2019 | Amendment | $10,695,495 | $10,695,495 | $0 | 6 | Nov 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637719000002/0001416377-19-000002-index.htm) |
| Dec 13, 2018 | New notice | $10,000,000 | $2,000,000 | $8,000,000 | 1 | Nov 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000160767718000004/0001607677-18-000004-index.htm) |
| Jul 2, 2018 | New notice | $8,500,000 | $2,685,000 | $5,815,000 | 27 | Jun 18, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637718000001/0001416377-18-000001-index.htm) |
| Apr 5, 2017 | New notice | $26,875,622 | $9,875,623 | $16,999,999 | 9 | Mar 23, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637717000004/0001416377-17-000004-index.htm) |
| Apr 4, 2012 | New notice | $16,000,000 | $6,499,999 | $9,500,001 | 10 | Mar 7, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637712000004/0001416377-12-000004-index.htm) |
| Aug 2, 2010 | Amendment | $16,124,045 | $16,064,150 | $59,895 | 12 | Jan 19, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637710000005/0001416377-10-000005-index.htm) |
| Feb 1, 2010 | New notice | $12,651,233 | $5,999,999 | $6,651,234 | 5 | Jan 19, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1416377/000141637710000004/0001416377-10-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Ivor Royston | Executive Officer, Director |  |
| Richard Ghalie | Director |  |
| Michael Huang | Director |  |
| Daniel Chevallard | Executive Officer |  |
| Roger Pomerantz | Director |  |
| Gur Roshwalb | Director |  |
| Samuel Murphy | Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Mar 8, 2021](https://specstream.ai/data/form-d/week/2021-03-08) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Viracta Subsidiary, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).